NCT00217737 · BASELINE

Baseline characteristics

Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer · Source last updated 2026-08-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
460
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1931
units
Participants

groups

description
Patients receive oxaliplatin IV over 2 hours and leucovorin calcium IV over 2 hours on day 1. Patients also receive fluorouracil IV continuously over 46 hours beginning on day 1. Treatment repeats every 2 weeks for 12 courses in the absence of disease progression or unacceptable toxicity.
id
BG000
title
Arm A (5-FU, Leucovorin, Oxaliplatin)
description
Patients receive oxaliplatin, leucovorin calcium, and fluorouracil as in Arm A and bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 2 weeks for 12 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone for 12 additional courses in the absence of disease progression or unacceptable toxicity.
id
BG001
title
Arm B (5-FU, Leucovorin, Oxaliplatin, Bevacizumab)
description
Patients undergo observation.
id
BG002
title
Arm C (Observation)
description
Total of all reporting groups
id
BG003
title
Total

measures

classes
categories
measurements
group Id
BG000
lower Limit
26
upper Limit
87
value
59
group Id
BG001
lower Limit
25
upper Limit
85
value
59
group Id
BG002
lower Limit
19
upper Limit
90
value
60
group Id
BG003
lower Limit
19
upper Limit
90
value
60
denoms
counts
group Id
BG000
value
460
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1931
units
Participants
dispersion Type
FULL_RANGE
param Type
MEDIAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
235
group Id
BG001
value
232
group Id
BG002
value
496
group Id
BG003
value
963
title
Female
measurements
group Id
BG000
value
224
group Id
BG001
value
226
group Id
BG002
value
517
group Id
BG003
value
967
title
Male
denoms
counts
group Id
BG000
value
459
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1930
units
Participants
param Type
COUNT_OF_PARTICIPANTS
population Description
One patient with unknown sex was excluded from the analysis of distribution of sex.
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
29
group Id
BG001
value
32
group Id
BG002
value
88
group Id
BG003
value
149
title
Hispanic or Latino
measurements
group Id
BG000
value
401
group Id
BG001
value
390
group Id
BG002
value
868
group Id
BG003
value
1659
title
Not Hispanic or Latino
measurements
group Id
BG000
value
30
group Id
BG001
value
36
group Id
BG002
value
57
group Id
BG003
value
123
title
Unknown or Not Reported
denoms
counts
group Id
BG000
value
460
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1931
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
1
group Id
BG001
value
2
group Id
BG002
value
0
group Id
BG003
value
3
title
American Indian or Alaska Native
measurements
group Id
BG000
value
17
group Id
BG001
value
14
group Id
BG002
value
32
group Id
BG003
value
63
title
Asian
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
group Id
BG003
value
0
title
Native Hawaiian or Other Pacific Islander
measurements
group Id
BG000
value
49
group Id
BG001
value
55
group Id
BG002
value
85
group Id
BG003
value
189
title
Black or African American
measurements
group Id
BG000
value
385
group Id
BG001
value
372
group Id
BG002
value
882
group Id
BG003
value
1639
title
White
measurements
group Id
BG000
value
2
group Id
BG001
value
0
group Id
BG002
value
0
group Id
BG003
value
2
title
More than one race
measurements
group Id
BG000
value
6
group Id
BG001
value
15
group Id
BG002
value
14
group Id
BG003
value
35
title
Unknown or Not Reported
denoms
counts
group Id
BG000
value
460
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1931
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Race (NIH/OMB)
unit Of Measure
Participants

population Description

All patients registered to Step 2 are included in this analysis.

Complete source fields

denoms

counts
group Id
BG000
value
460
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1931
units
Participants

groups

description
Patients receive oxaliplatin IV over 2 hours and leucovorin calcium IV over 2 hours on day 1. Patients also receive fluorouracil IV continuously over 46 hours beginning on day 1. Treatment repeats every 2 weeks for 12 courses in the absence of disease progression or unacceptable toxicity.
id
BG000
title
Arm A (5-FU, Leucovorin, Oxaliplatin)
description
Patients receive oxaliplatin, leucovorin calcium, and fluorouracil as in Arm A and bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 2 weeks for 12 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone for 12 additional courses in the absence of disease progression or unacceptable toxicity.
id
BG001
title
Arm B (5-FU, Leucovorin, Oxaliplatin, Bevacizumab)
description
Patients undergo observation.
id
BG002
title
Arm C (Observation)
description
Total of all reporting groups
id
BG003
title
Total

measures

classes
categories
measurements
group Id
BG000
lower Limit
26
upper Limit
87
value
59
group Id
BG001
lower Limit
25
upper Limit
85
value
59
group Id
BG002
lower Limit
19
upper Limit
90
value
60
group Id
BG003
lower Limit
19
upper Limit
90
value
60
denoms
counts
group Id
BG000
value
460
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1931
units
Participants
dispersion Type
FULL_RANGE
param Type
MEDIAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
235
group Id
BG001
value
232
group Id
BG002
value
496
group Id
BG003
value
963
title
Female
measurements
group Id
BG000
value
224
group Id
BG001
value
226
group Id
BG002
value
517
group Id
BG003
value
967
title
Male
denoms
counts
group Id
BG000
value
459
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1930
units
Participants
param Type
COUNT_OF_PARTICIPANTS
population Description
One patient with unknown sex was excluded from the analysis of distribution of sex.
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
29
group Id
BG001
value
32
group Id
BG002
value
88
group Id
BG003
value
149
title
Hispanic or Latino
measurements
group Id
BG000
value
401
group Id
BG001
value
390
group Id
BG002
value
868
group Id
BG003
value
1659
title
Not Hispanic or Latino
measurements
group Id
BG000
value
30
group Id
BG001
value
36
group Id
BG002
value
57
group Id
BG003
value
123
title
Unknown or Not Reported
denoms
counts
group Id
BG000
value
460
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1931
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
1
group Id
BG001
value
2
group Id
BG002
value
0
group Id
BG003
value
3
title
American Indian or Alaska Native
measurements
group Id
BG000
value
17
group Id
BG001
value
14
group Id
BG002
value
32
group Id
BG003
value
63
title
Asian
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
group Id
BG003
value
0
title
Native Hawaiian or Other Pacific Islander
measurements
group Id
BG000
value
49
group Id
BG001
value
55
group Id
BG002
value
85
group Id
BG003
value
189
title
Black or African American
measurements
group Id
BG000
value
385
group Id
BG001
value
372
group Id
BG002
value
882
group Id
BG003
value
1639
title
White
measurements
group Id
BG000
value
2
group Id
BG001
value
0
group Id
BG002
value
0
group Id
BG003
value
2
title
More than one race
measurements
group Id
BG000
value
6
group Id
BG001
value
15
group Id
BG002
value
14
group Id
BG003
value
35
title
Unknown or Not Reported
denoms
counts
group Id
BG000
value
460
group Id
BG001
value
458
group Id
BG002
value
1013
group Id
BG003
value
1931
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Race (NIH/OMB)
unit Of Measure
Participants

population Description

All patients registered to Step 2 are included in this analysis.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Independent clinical review pending · Not medical advice